Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 283.83M | 292.08M | 292.27M | 300.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 283.83M | 292.08M | 292.27M | 300.94M |
| Cost of Revenue | -- | 165.32M | 164.78M | 164.78M | 163.56M |
| Gross Profit | -- | 118.51M | 127.30M | 127.49M | 137.38M |
| SG&A Expenses | -- | 116.44M | 106.82M | 106.63M | 111.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 656.00K | 2.72M | 3.14M | 7.11M |
| Total Operating Expenses | -- | 282.42M | 274.32M | 274.55M | 282.44M |
| Operating Income | -- | 1.41M | 17.76M | 17.72M | 18.50M |
| Income Before Tax | -- | -112.65M | -49.54M | -49.45M | -16.19M |
| Income Tax Expenses | -- | -15.82M | -6.70M | -6.86M | -6.02M |
| Earnings from Continuing Operations | -- | -96.83 | -42.84 | -42.60 | -10.18 |
| Earnings from Discontinued Operations | -- | -- | 23.94M | 23.67M | 40.05M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 44.00K |
| Net Income | -- | -96.83M | -19.13M | -19.17M | 29.68M |
| EBIT | -- | 1.41M | 17.76M | 17.72M | 18.50M |
| EBITDA | -- | 13.56M | 30.34M | 29.72M | 66.44M |
| EPS Basic | -- | -0.19 | -0.03 | -0.04 | 0.07 |
| Normalized Basic EPS | -- | -0.17 | -0.11 | -0.02 | -0.06 |
| EPS Diluted | -- | -0.20 | -0.03 | -0.03 | 0.07 |
| Normalized Diluted EPS | -- | -0.17 | -0.11 | -0.02 | -0.06 |
| Average Basic Shares Outstanding | -- | 1.95B | 1.92B | 1.90B | 1.90B |
| Average Diluted Shares Outstanding | -- | 1.95B | 1.92B | 1.90B | 1.90B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -0.89% | -0.89% | 0.58% |